All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. Effects and costs of pneumococcal conjugate vaccination of Belgian children

    KCE Reports 33 (2006)

    https://kce.fgov.be/en/effects-and-costs-of-pneumococcal-conjugate-vaccination-of-belgian-children

  2. Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium.

    KCE Reports 36 (2006) August 2006 (3rd edition ; 2nd edition : July 2006 ; 1st edition : June 2006)

    https://kce.fgov.be/en/pharmacological-and-surgical-treatment-of-obesity-residential-care-for-severely-obese-children-in

  3. [Home Monitoring of Infants in Prevention of Sudden Infant Death Syndrome]

    KCE Reports 46 (2006)

    https://kce.fgov.be/en/home-monitoring-of-infants-in-prevention-of-sudden-infant-death-syndrome

  4. Cost-effectiveness analysis of rotavirus vaccination of Belgian infants

    KCE Reports 54 (2007)

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-rotavirus-vaccination-of-belgian-infants

  5. [Is neonatal screening for cystic fibrosis recommended in Belgium?]

    KCE Reports 132 (2010)

    https://kce.fgov.be/en/is-neonatal-screening-for-cystic-fibrosis-recommended-in-belgium

  6. [Cost-utility of Vaccination against Chickenpox in Children and against Herpes Zoster in Elderly in Belgium]

    KCE Reports 151 (2010)

    https://kce.fgov.be/en/cost-utility-of-vaccination-against-chickenpox-in-children-and-against-herpes-zoster-in-elderly-in

  7. Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood

    KCE Reports 155 (2011)

    https://kce.fgov.be/en/cost-effectiveness-of-10-and-13-valent-pneumococcal-conjugate-vaccines-in-childhood

  8. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii

  9. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study

  10. Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers

    KCE Reports 235 (2015)

    https://kce.fgov.be/en/hadron-therapy-in-children-%E2%80%93-an-update-of-the-scientific-evidence-for-15-paediatric-cancers